| Literature DB >> 30349329 |
Fatemeh Keihanian1, Amin Saeidinia1,2, Keivan Abbasi1, Faeze Keihanian2,3,4,5.
Abstract
INTRODUCTION: Septicemia is an emergency in medicine due to various dangers and lethality. In patients with septicemia, blood culture and other cultures should be done before antibiotic therapy. Determination of each isolated bacterium from blood culture and pattern of antibiotic sensitivity have an important role epidemiologically in a region and can assist physicians in the determination of primary antimicrobial agents. In this study, the researchers evaluated the schema of resistance of antibiotics in blood culture during the years 2014-2015 at eight educational hospitals in Rasht, North of Iran.Entities:
Keywords: antibiotic resistance; blood culture; empiric therapy; pattern of antibiograms
Year: 2018 PMID: 30349329 PMCID: PMC6188111 DOI: 10.2147/IDR.S169176
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.003
Distribution of bacteria in positive blood culture cases
| Bacteria isolated from the blood cultures | Frequency | Percent |
|---|---|---|
| 66 | 29.3 | |
| 30 | 13.3 | |
| 29 | 12.9 | |
| 28 | 12.4 | |
| 24 | 10.7 | |
| 20 | 8.9 | |
| 17 | 7.6 | |
| 5 | 2.2 | |
| 4 | 1.8 | |
| 1 | 0.4 | |
| 1 | 0.4 | |
| Total | 225 | 100.0 |
Usage of antibiotic discs in antibiograms and their patterns
| Antibiotic | Sensitive, n (%) | Intermediate, n (%) | Resistance, n (%) | Usage, n (%) |
|---|---|---|---|---|
|
| ||||
| Ampicillin | 11 (4.9) | 5 (2.2) | 122 (54.2) | 138 (61.3) |
| Ceftizoxime | 54 (24.0) | 11 (4.9) | 110 (48.9) | 175 (77.8) |
| Ceftriaxone | 45 (20.0) | 17 (7.6) | 108 (48.0) | 170 (75.6) |
| Cotrimoxazole | 45 (20.0) | 6 (2.7) | 98 (43.6) | 149 (66.2) |
| Cefalotin | 22 (9.8) | 7 (3.1) | 80 (35.6) | 109 (48.4) |
| Cefazolin | 11 (4.9) | 3 (1.3) | 71 (31.6) | 85 (37.8) |
| Cefotaxime | 38 (16.9) | 27 (12.0) | 63 (28.0) | 128 (56.9) |
| Ceftazidime | 51 (22.7) | 16 (7.1) | 62 (27.6) | 129 (57.3) |
| Gentamicin | 64 (28.4) | 22 (9.8) | 56 (24.9) | 142 (63.1) |
| Nitrofurantoin | 22 (9.8) | 2 (0.9) | 52 (23.1) | 76 (33.8) |
| Nalidixic acid | 57 (25.3) | 4 (1.8) | 45 (20.0) | 106 (47.1) |
| Ciprofloxacin | 125 (55.6) | 4 (1.8) | 43 (19.1) | 172 (76.4) |
| Cefixime | 0 (0) | 0 (0) | 38 (16.9) | 38 (16.9) |
| Amikacin | 115 (51.1) | 6 (2.7) | 33 (14.7) | 154 (68.4) |
| Imipenem | 58 (25.8) | 5 (2.2) | 25 (11.1) | 88 (39.1) |
| Erythromycin | 7 (3.1) | 13 (5.8) | 20 (8.9) | 40 (17.8) |
| Vancomycin | 52 (23.1) | 8 (3.6) | 17 (7.6) | 77 (34.2) |
| Piperacillin | 15 (6.7) | 4 (1.8) | 15 (6.7) | 34 (15.1) |
| Cephalexin | 19 (8.4) | 3 (1.3) | 14 (6.2) | 36 (16.0) |
| Kanamycin | 9 (4.0) | 19 (8.4) | 9 (4.0) | 37 (16.4) |
| Amoxicillin | 0 (0) | 0 (0) | 7 (3.1) | 7 (3.1) |
| Chloramphenicol | 6 (2.7) | 3 (1.3) | 6 (2.7) | 15 (6.7) |
| Clindamycin | 5 (2.2) | 1 (0.4) | 5 (2.2) | 11 (4.9) |
| Tobramycin | 4 (1.8) | 0 (0) | 5 (2.2) | 9 (4.0) |
| Penicillin | 0 (0) | 0 (0) | 5 (2.2) | 5 (2.2) |
| Tetracycline | 0 (0) | 0 (0) | 1 (0.4) | 1 (0.4) |
| Doxycycline | 0 (0) | 0 (0) | 1 (0.4) | 1 (0.4) |
| Methicillin | 0 (0) | 0 (0) | 1 (0.4) | 1 (0.4) |
| Cefepime | 0 (0) | 0 (0) | 1 (0.4) | 1 (0.4) |
Antibiotic resistance in common bacterial groups in blood cultures performed
| Most common bacteria
| The most common antibiotics used | |||||||
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| 10.4% | 12.8% | 8% | 13.6% | 11.2% | 11.2% | 28% | Sensitivity | Ciprofloxacin |
| 4.7% | 11.6% | 25.6% | 16.3% | 7% | 16.3% | 18.6% | Resistance | |
| 25% | – | – | 50% | – | 50% | – | Interstitial | |
| 13.7% | 15.7% | 13.7% | 3.9% | – | 3.9% | 45.1% | Sensitivity | Ceftazidime |
| 1.6% | 11.3% | 11.3% | 16.1% | 3.2% | 16.1% | 37.1% | Resistance | |
| 25% | 18.8% | 6.3% | 18.8% | – | 12.5% | 12.5% | Interstitial | |
| – | 9.1% | 27.3% | 9.1% | – | 54.5% | – | Sensitivity | Ampicillin |
| 9.8% | 12.3% | 10.7% | 15.6% | 2.5% | 9.8% | 35.2% | Resistance | |
| 20% | 40% | – | – | – | – | 20% | Interstitial | |
| 5.6% | 11.1% | 14.8% | 24.1% | 13% | 27.8% | – | Sensitivity | Ceftizoxime |
| 2.7% | 12.7% | 10.9% | 10% | 6.4% | 4.5% | 41.8% | Resistance | |
| – | 18.2% | 9.1% | – | 36.4% | 27.3% | – | Interstitial | |
| 10.4% | 13.9% | 15.7% | 14.8% | – | 14.8% | 28.7% | Sensitivity | Amikacin |
| 6.1% | 9.1% | 3% | – | 9.1% | 3% | 60.6% | Resistance | |
| 16.7% | 50% | 16.7% | 16.7% | – | – | – | Interstitial | |
| 15.6% | 15.6% | 20% | 13.3% | – | 17.8% | 11.1% | Sensitivity | Cotrimoxazole |
| 10.2% | 14.3% | 14.3% | 9.2% | 1% | 9.2% | 36.7% | Resistance | |
| – | 16.7% | 16.7% | 16.7% | – | 16.7% | 33.3% | Interstitial | |
| 6.3% | 12.5% | 21.9% | 18.8% | 3.1% | 18.8% | 14.1% | Sensitivity | Gentamicin |
| 8.9% | 12.5% | 8.9% | 8.9% | 8.9% | 7.1% | 41.1% | Resistance | |
| 13.6% | 4.5% | 13.6% | 22.7% | 27.3% | 9.1% | 9.1% | Interstitial | |
| 2.6% | 15.8% | 21.1% | 18.4% | 15.8% | 21.1% | 2.6% | Sensitivity | Cefotaxime |
| 12.7% | 11.1% | 9.5% | 4.8% | 6.3% | 6.3% | 44.4% | Resistance | |
| 11.1% | 18.5% | – | 7.4% | 18.5% | 14.8% | 29.6% | Interstitial | |
| 2.2% | 4.4% | 15.6% | 28.9% | 15.6% | 28.9% | – | Sensitivity | Ceftriaxone |
| 8.2% | 11.1% | 7.4% | 6.5% | 10.2% | 7.4% | 41.7% | Resistance | |
| – | 35.3% | 11.8% | 11.8% | 11.8% | 17.6% | 11.8% | Interstitial | |
| – | – | 9.1% | 31.8% | 27.3% | 31.8% | – | Sensitivity | Cefalotin |
| 15% | 11.3% | 10% | 5% | 3.8% | 7.5% | 42.5% | Resistance | |
| 14.3% | 14.3% | – | – | 57.1% | 14.3% | – | Interstitial | |
Antibiotic resistance in common bacterial groups in blood cultures performed after adjustment
| Antibiotic | Frequency (%) |
|---|---|
|
| |
| Ampicillin | 127 (56.4) |
| Ceftriaxone | 125 (55.5) |
| Ceftizoxime | 121 (53.7) |
| Cotrimoxazole | 104 (46.2) |
| Cefotaxime | 90 (40) |
| Cefalotin | 87 (38.6) |
| Gentamicin | 78 (34.6) |
| Ceftazidime | 78 (34.6) |
| Cefazolin | 74 (32.8) |
| Nitrofurantoin | 54 (24) |
| Nalidixic acid | 49 (21.7) |
| Ciprofloxacin | 47 (20.8) |
| Amikacin | 39 (17.3) |
| Cefixime | 38 (16.8) |
| Erythromycin | 33 (14.6) |